CTC
HAE icon

Cetera Trust Company’s Haemonetics HAE Stock Holding History

Cetera Trust Company’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Buy
4,670
+220
+5% +$14.1K 0.18% 109
2026
Q1 		$251K Hold
4,450
– – 0.14% 134
2025
Q4 		$357K Buy
4,450
+75
+2% +$5.04K 0.19% 91
2025
Q3 		$213K Buy
+4,375
New +$271K 0.12% 159

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Trust Company's HAE Position: Q2 2026 in Review

Cetera Trust Company increased its Haemonetics (HAE) stake by 4.9% in Q2 2026, buying an estimated $14.1K and bringing the position to 4,670 shares worth $350K. The position accounts for 0.18% of the portfolio, ranked #109.

Cetera Trust Company first reported a position in HAE in Q3 2025 and has held it in 4 quarters since. The position peaked at $357K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Cetera Trust Company held 4,670 shares of Haemonetics worth $350K as of Q2 2026.
  • Cetera Trust Company bought 220 Haemonetics shares in Q2 2026, an estimated $14.1K.
  • Haemonetics made up 0.18% of Cetera Trust Company's portfolio in Q2 2026, its #109 holding.
  • Cetera Trust Company first reported a position in Haemonetics in Q3 2025 and has held it in 4 quarters since.
  • Cetera Trust Company's Haemonetics position peaked at $357K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.